Overview

Brain Imaging in Tobacco Smokers During a Quit Attempt

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
0
Participant gender:
All
Summary
The proposed study will help fill gaps in existing research by determining if nicotine-dependent cigarette smokers show changes in α7 nicotinic acetylcholine receptor (nAChR) availability when compared to matched historical controls using positron emission tomography (PET) imaging and the radioactive ligand [18F]-ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6 [18F]fluorodibenzo[b,d]thiophene 5,5-dioxide), an α7 nAChR antagonist. The study will also explore whether α7 nAChR availability influences clinically relevant measures of tobacco abstinence (e.g., withdrawal and craving, cognitive impairment), self-reported cigarettes per day, and time to relapse during an 8-day quit attempt during which smokers can receive escalating payments contingent upon providing objective evidence (breath CO and urinary cotinine) of smoking abstinence.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Acetylcholine
Criteria
Inclusion Criteria:

- Subjects must be healthy volunteers

- Regular tobacco smokers for a period of 2 or more years

- Positive breath carbon monoxide (CO)

- Cotinine positive urine test

- Meet DSM-V criteria for tobacco use disorder.

Exclusion Criteria:

- Meets DSM-5 criteria for alcohol use disorder or substance use disorder (excluding
tobacco use disorder)

- Meets DSM-5 Psychiatric Disorder; in or in need of treatment

- History of seizures, seizure disorder or closed head trauma

- HIV positive

- Weight > 350 lbs

- < 5th grade reading level

- Recent use of smoking cessation products

- If female: pregnant, lactating, planning pregnancy; positive urine pregnancy screen

- Any condition which would preclude MRI

- Radiation exposure in the last year that when combined with the study protocol would
exceed the annual limits.